ArticleBreast cancer research : BCR2013
GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.
Zhiqiang Mo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
76 papers cite itlatest 60 shown
this papercites it